Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
64.42 USD | -1.40% | -1.47% | -20.43% |
May. 02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
May. 01 | Deutsche Bank Adjusts Price Target on Gilead Sciences to $73 From $75 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.43% | 81.46B | |
+26.69% | 681B | |
+21.85% | 556B | |
-5.09% | 361B | |
+17.13% | 325B | |
+5.18% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-4.29% | 157B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Argus Cuts Price Target on Gilead Sciences to $75 From $85